FROSINI MARIA

Maria
Frosini
Dipartimento di Scienze della Vita
Professore Associato

Office hours

  • Monday from 11:00 to 12:00
    Place: Studio del Docente - Polo Scientifico di San Miniato, stanza C_01_187 (ex stanza 10312) I piano, settore C
    Note: Previo appuntamento per telefono (0577235355) o per email (maria.frosini@unisi.it)

Please ask the Professor for an appointment by phone (+390577235355) or email (maria.frosini@unisi.it)

Contacts

maria.frosini@unisi.it
0577235355 [int.5355] (Studio),0577232086 [int.2086] (Laboratorio),0577232087 [int.2087] (Laboratorio)

Curriculum Vitae

cv

Teaching activities

Completion accademic year: 2025/2026

PHARMACOLOGY
Course year: 2 First cycle degree (DM 270) Dental Hygiene A.Y. 2024/2025
PHARMACOLOGY
Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2023/2024
PHARMACOLOGY AND PHARMACOTHERAPY - (FIRST MODULE)
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023

Completion accademic year: 2024/2025

PHARMACOLOGY
Course year: 1 ORTOGNATODONZIA A.Y. 2024/2025
PHARMACOLOGY
Course year: 2 First cycle degree (DM 270) Dental Hygiene A.Y. 2023/2024
PHARMACOLOGY
Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2022/2023
PHARMACOLOGY - PA
Course year: 1 ORTOGNATODONZIA A.Y. 2024/2025
PHARMACOLOGY AND PHARMACOTHERAPY - (FIRST MODULE)
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022

Completion accademic year: 2023/2024

PHARMACOLOGY
Course year: 1 ORTOGNATODONZIA A.Y. 2023/2024
PHARMACOLOGY
Course year: 2 First cycle degree (DM 270) Dental Hygiene A.Y. 2022/2023

Registration for exams

Research

Ultime pubblicazioni:

  • Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - view more
  • Cursaro, I., Frattaruolo, L., Scalvini, L., Contri, C., Bichicchi, A., Tardiolo, N., et al. (2025). New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells. BIOORGANIC CHEMISTRY, 166 [10.1016/j.bioorg.2025.109085]. - view more
  • Poggialini, F., Rango, E., Vagaggini, C., Diana, S., Brai, A., Grossi, G., et al. (2025). Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 683 [10.1016/j.ijpharm.2025.126001]. - view more
  • Camarda, L., Corazza, I., Locatelli, A., Leoni, A., Frosini, M., Budriesi, R., et al. (2025). Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility. PHARMACEUTICALS, 18(10) [10.3390/ph18101476]. - view more
  • Filippelli, A., Ciccone, V., Del Gaudio, C., Simonis, V., Frosini, M., Tusa, I., et al. (2024). ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1871(7) [10.1016/j.bbamcr.2024.119810]. - view more
All publications